美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
59762-1001-1	59762-1001	HUMAN PRESCRIPTION DRUG	Sirolimus	SIROLIMUS	TABLET, SUGAR COATED	ORAL	20140107	N/A	NDA AUTHORIZED GENERIC	NDA021110	Mylan Pharmaceuticals Inc.	SIROLIMUS	.5 mg/1	100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1001-1)
59762-1003-1	59762-1003	HUMAN PRESCRIPTION DRUG	Sirolimus	SIROLIMUS	TABLET, SUGAR COATED	ORAL	20141027	N/A	NDA AUTHORIZED GENERIC	NDA021110	Mylan Pharmaceuticals Inc.	SIROLIMUS	2 mg/1	100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1)
59762-1002-1	59762-1002	HUMAN PRESCRIPTION DRUG	Sirolimus	SIROLIMUS	TABLET, SUGAR COATED	ORAL	20141027	N/A	NDA AUTHORIZED GENERIC	NDA021110	Mylan Pharmaceuticals Inc.	SIROLIMUS	1 mg/1	100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1002-1)
0008-1041-05	0008-1041	HUMAN PRESCRIPTION DRUG	Rapamune	SIROLIMUS	TABLET, SUGAR COATED	ORAL	20010701	20251231	NDA	NDA021110	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	SIROLIMUS	1 mg/1	100 TABLET, SUGAR COATED in 1 BOTTLE (0008-1041-05)